KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Davita (DVA) Gains from Sales and Divestitures (2012 - 2016)

Davita (DVA) reported Gains from Sales and Divestitures of $5000.0 for Q4 2016, down 98.56% year-over-year from $348127.0 in Q1 2016, and down 98.56% on a QoQ basis from $348127.0 in Q4 2015.

Davita (DVA) has 5 years of Gains from Sales and Divestitures data on file, last reported at $5000.0 in Q4 2016.

  • Quarterly Gains from Sales and Divestitures fell 98.56% year-over-year to $5000.0 in Q4 2016, while the trailing twelve-month figure through Dec 2016 was $5000.0 (down 98.56% YoY) and the FY2016 annual result came in at $5000.0, down 98.56% from the prior year.
  • Gains from Sales and Divestitures retreated to $5000.0 in Q4 2016 per DVA's latest filing, from $348127.0 in the prior quarter.
  • Across five years, Gains from Sales and Divestitures topped out at $348127.0 in Q4 2015 and bottomed at $3125.0 in Q4 2012.
  • The 5-year median for Gains from Sales and Divestitures is $16875.0 (2013), against an average of $135419.4.
  • The widest annual swing landed in 2014, when Gains from Sales and Divestitures surged 1701.3%; it then plunged 98.56% in 2016.
  • Tracing DVA's Gains from Sales and Divestitures over 5 years: stood at $3125.0 in 2012, then jumped by 440.0% to $16875.0 in 2013, then surged by 1701.3% to $303970.0 in 2014, then rose by 14.53% to $348127.0 in 2015, then sank by 98.56% to $5000.0 in 2016.
  • Per Business Quant, the three latest DVA Gains from Sales and Divestitures figures stand at $5000.0 (Q4 2016), $348127.0 (Q4 2015), and $303970.0 (Q4 2014).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 84.64 Bn 87.02 Bn 16.26 Bn
2 Tenet Healthcare 15.22 Bn 14.39 Bn 4.41 Bn
3 Davita 13.10 Bn 13.96 Bn 1.07 Bn
4 Encompass Health 10.50 Bn 11.12 Bn 1.34 Bn
5 Ensign 9.69 Bn 9.09 Bn 293.37 Mn
6 Universal Health Services 8.92 Bn 8.88 Bn 3.21 Bn
7 Fresenius Medical Care AG 7.31 Bn 4.93 Bn 22,843.10 Bn
8 Chemed 5.83 Bn 5.81 Bn 215.76 Mn
9 Pacs 5.76 Bn 5.51 Bn 345.96 Mn
10 Option Care Health 3.27 Bn 3.09 Bn 262.01 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2016 5,000.00
Dec 31, 2016 5,000.00
Dec 31, 2015 348,127.00
Dec 31, 2015 348,127.00
Dec 31, 2014 303,970.00
Dec 31, 2014 303,970.00
Dec 31, 2013 16,875.00
Dec 31, 2013 16,875.00
Dec 31, 2012 3,125.00
Dec 31, 2012 3,125.00